Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia.
about
Kyoto global consensus report on Helicobacter pylori gastritisGastric cancer: prevention, screening and early diagnosisHistological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysisManagement of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuHelicobacter pylori eradication for preventing gastric cancerLong-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria.The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesisAlteration of histological gastritis after cure of Helicobacter pylori infection.Review article: test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention?Active and inactive gastroesophageal reflux diseases related to Helicobacter pylori therapy.Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancerConcomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia.Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trialIncidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population.The story so far: Helicobacter pylori and gastric autoimmunity.Helicobacter pylori eradication and associated changes in the gastric mucosa.Helicobacter pylori: immunoproteomics related to different pathologies.Treatment of Helicobacter pylori and prevention of gastric cancer.Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing.An inverse relationship between the expression of the gastric tumor suppressor RUNX3 and infection with Helicobacter pylori in gastric epithelial dysplasiaExpression of CDX2 in gastric cardia adenocarcinoma and its correlation with H. pylori and cell proliferation.Intestinal metaplasia and the risk of gastric cancer in an immigrant asian population.Helicobacter pylori: gastric cancer and extragastric intestinal malignancies.Helicobacter pylori and gastric cancer: a state of the art review.Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease.Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond.Serum-free culture of H pylori intensifies cytotoxicity.The time to eradicate gastric cancer is nowHelicobacter pylori eradication induces marked increase in H+/K+-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosaTime trend occurrence of duodenal intraepithelial lymphocytosis and celiac disease in an open access endoscopic population.Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis.Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection.Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection.The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis.Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus.The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.Effect of acid suppression therapy on development of gastric erosions after cure of Helicobacter pylori infection.Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori.Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
P2860
Q26799430-3375C184-BC0B-4F96-B86C-74B8FC31EC95Q26860418-9D4E0637-88E5-49F6-A5E9-86561F0A0702Q26864431-C2DB07CD-6231-42BE-A297-A48C9862525FQ30426539-D08AABA2-F575-44F0-9AC1-CB45EDB569AEQ33626785-A2686096-1720-476B-825E-7DEF671C892BQ34321913-88478088-67CF-4BE2-B036-8E339D97EE05Q34959399-AF4733EB-497A-40A1-8538-5831DBF10EF2Q34975851-B8F38964-976A-4079-8DA0-709A7226FA65Q35145055-911D3876-8F72-419A-9884-EE4E7FE6F6C1Q35209726-82AD4CEB-C300-4CFA-BF4F-901EE6A14CB8Q35261353-149B8A6C-1C74-47DC-91D0-930226D46E3FQ35595511-2AF8EA2A-A153-490B-BA37-1A49E873E17DQ35596265-F6DDA173-BDE0-4590-9D02-10D36F2B422EQ35892294-BA3B11E1-A619-48A6-8165-B5B2A4EE6013Q36069504-0B485268-33FB-4215-AF5A-EBBD51676154Q36278059-E00CE0C3-8FA6-4F5A-9C03-B206B61840B1Q36973785-CB9137E4-72C0-4846-9B44-8C41DC262CFBQ37077697-7E5A629B-8AE8-41F1-BD42-B72986675908Q37134943-0EEB74C4-9872-487B-8A2B-175666C8770CQ37359360-FCB4B5B5-29D8-4BFC-8A3A-D8E9CEE4BA92Q37688172-9680471E-D3C0-4EC5-B941-7F3C147CB37CQ37704530-C47F095E-12D9-4588-9F16-F1D31F678883Q38041643-8A253D82-9FA0-4CB3-BC61-222732726B64Q38546560-34FEA3CE-6C52-4F89-A343-FCBC26D57E34Q39104046-694BCEBE-33E8-4796-8603-BD98AA74BDA4Q40108447-E65988DE-F869-420D-BC0C-2515CAB459AEQ40970496-92B24615-22AC-4470-B11E-1582A1B27A9AQ41824540-0B364FCF-134E-4C4E-B883-C2C2DDFAD343Q42267530-8D80F3C6-58BB-4068-877E-20B0330864A3Q42284235-8FAFCF48-8384-42EA-AEBB-DE3CF5D5D0D4Q42716561-3BDBEBC7-2DED-47D3-8DF6-746D91C67990Q43767083-0CB5D1F2-2358-49C1-A87A-0FA3515DEB1AQ43782286-78869760-06E7-465E-84BC-98E6857EB32EQ43872203-C5DB5997-BBD1-4C02-B016-31939F7CDD97Q43892515-289A8980-FAD0-4D44-B417-10CE01F45C4DQ43904277-0A4872C7-7A32-4B76-A475-3D8D58768C66Q43967161-B84433B5-A3F6-4B0B-81AE-636DD8A375A4Q44016286-CFC73097-E337-43D6-ADA4-4A66D65BA436Q44766470-A3A8C23B-E7FE-4FA4-B1A4-9ECA40747F79Q45009863-3722EED7-2C4F-404B-94D3-05C4090AC95D
P2860
Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Cure of Helicobacter pylori in ...... on body ECL-cell hyperplasia.
@en
Cure of Helicobacter pylori in ...... on body ECL-cell hyperplasia.
@nl
type
label
Cure of Helicobacter pylori in ...... on body ECL-cell hyperplasia.
@en
Cure of Helicobacter pylori in ...... on body ECL-cell hyperplasia.
@nl
prefLabel
Cure of Helicobacter pylori in ...... on body ECL-cell hyperplasia.
@en
Cure of Helicobacter pylori in ...... on body ECL-cell hyperplasia.
@nl
P2093
P2860
P1476
Cure of Helicobacter pylori in ...... on body ECL-cell hyperplasia.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2000.00752.X
P407
P577
2000-05-01T00:00:00Z